Morgan Stanley (MS)
202.58
-0.94 (-0.46%)
NYSE · Last Trade: Sep 19th, 11:21 AM EDT
Detailed Quote
| Previous Close | 203.52 |
|---|---|
| Open | 202.10 |
| Bid | 202.63 |
| Ask | 202.99 |
| Day's Range | 200.85 - 203.05 |
| 52 Week Range | 151.84 - 232.25 |
| Volume | 7,501,367 |
| Market Cap | 369.62B |
| PE Ratio (TTM) | 19.84 |
| EPS (TTM) | 10.2 |
| Dividend & Yield | 4.600 (2.27%) |
| 1 Month Average Volume | 4,631,323 |
Chart
About Morgan Stanley (MS)
Morgan Stanley is a leading global financial services firm that provides a wide range of services in investment banking, securities, wealth management, and investment management. Catering to a diverse clientele that includes corporations, governments, and individuals, Morgan Stanley offers expert advisory and financing services, helping clients navigate complex financial markets and achieve their financial objectives. The firm is known for its strategic insights, innovative solutions, and commitment to delivering exceptional service, positioning itself as a trusted partner in the world of finance. Read More
News & Press Releases
Wall Street remains very bullish on SpaceX stock.
Via The Motley Fool · September 19, 2026
United Rentals (NYSE:URI) executives said construction-equipment rental demand has exceeded the company’s expectations this year, led by an accelerating pipeline of large projects and supported by continued strength in specialty rental operations.
Speaking at a Morgan Stanley event, Chief Executive
Via MarketBeat · September 19, 2026
Ionis Pharmaceuticals (NASDAQ:IONS) CEO Brett Monia outlined recent regulatory wins, commercial-launch progress and several pipeline updates at the Morgan Stanley Global Healthcare Conference, while acknowledging setbacks in late-stage cardiovascular studies.
Monia said the company has secured two
Via MarketBeat · September 19, 2026
Intellia Therapeutics (NASDAQ:NTLA) executives outlined plans for a potential launch of its hereditary angioedema treatment, lonvo-z, while discussing the company’s ongoing Phase III program in transthyretin amyloidosis and its capital position during a Morgan Stanley event.
Chief Executive Officer
Via MarketBeat · September 19, 2026
BioCryst Pharmaceuticals (NASDAQ:BCRX) is shifting its strategy toward external innovation as it seeks to expand beyond its ORLADEYO hereditary angioedema, or HAE, franchise, newly appointed Chief Executive Officer Charlie Gayer said at a Morgan Stanley event.
Gayer, who became CEO on Jan. 1, said
Via MarketBeat · September 18, 2026
Arrowhead Pharmaceuticals (NASDAQ:ARWR) executives outlined early clinical data for its RNA interference dimer program, progress in the launch of plozasiran and plans for central nervous system and metabolic disease candidates during the Morgan Stanley Global Healthcare Conference.
Early Dimer Data
Via MarketBeat · September 18, 2026
L3Harris Technologies (NYSE:LHX) is entering its leadership transition with an emphasis on operating execution rather than further portfolio reshaping, according to Chief Financial Officer Ken Sharp.
Speaking at a Morgan Stanley aerospace and defense conference, Sharp said new Chief Executive Offic
Via MarketBeat · September 18, 2026
SpaceX's valuation now hovers just below $2 trillion.
Via The Motley Fool · September 18, 2026
After a blockbuster 2026 debut, where will SpaceX be in 2031?
Via The Motley Fool · September 18, 2026
BioMarin Pharmaceutical (NASDAQ:BMRN) said it is progressing with the integration of Amicus Therapeutics while pursuing additional business-development opportunities, as executives outlined growth plans for newly acquired rare-disease products, VOXZOGO and several pipeline programs at Morgan Stanley
Via MarketBeat · September 18, 2026
What Happened? Shares of global professional services company Accenture (NYSE:ACN) fell 3.3% in the afternoon session after Guggenheim analyst Jonathan Lee d...
Via StockStory · September 18, 2026
J.B. Hunt warned of higher driver-related costs, sending shares down, but analysts trimmed price targets while raising others, keeping a Moderate Buy rating amid sector-wide trucking pressure.
Via MarketBeat · September 18, 2026
NovoCure (NASDAQ:NVCR) outlined its strategy for returning its glioblastoma franchise to growth, expanding launches in pancreatic and lung cancer, and moving toward profitability during the Morgan Stanley Healthcare Conference.
Chief Executive Officer Frank Leonard said the company, founded more th
Via MarketBeat · September 18, 2026
Nvidia, Alphabet, and AMD have already bought most of the high bandwidth memory that will be manufactured next year.
Via The Motley Fool · September 18, 2026
AI investors should choose carefully as interest rates rise.
Via The Motley Fool · September 18, 2026
GE Vernova (NYSE:GEV) expects to reach its previously stated $200 billion backlog target early in 2027, supported by continued demand for power-generation and electrification equipment, Chief Executive Officer and President Scott Strazik said at Morgan Stanley’s Laguna Conference.
The company ended
Via MarketBeat · September 18, 2026
The two lead advisors generated record revenue in Q2, fueled by the SpaceX IPO. Will the Anthropic IPO have a similar impact?
Via The Motley Fool · September 18, 2026
Zoetis (NYSE:ZTS) executives said the company remains confident in its previously issued guidance despite pressure in the U.S. companion-animal market, citing a weaker pet-care environment and intensified competition in dermatology and parasiticides.
Speaking at a Morgan Stanley conference, CEO Kri
Via MarketBeat · September 18, 2026
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Via StockStory · September 18, 2026
Norfolk Southern (NYSE:NSC) said higher fuel prices are expected to pressure its operating ratio in the second half of the year, reversing the tailwind management had anticipated just two months earlier, while the railroad sees opportunities to gain freight share from trucking and continue investing
Via MarketBeat · September 17, 2026
Joby Aviation is flying high over a multitrillion-dollar opportunity.
Via The Motley Fool · September 17, 2026
Northrop Grumman (NYSE:NOC) Chairman and CEO Kathy Warden said the defense contractor is operating in what she described as a robust demand environment, supported by U.S. national-security spending, international demand and growth across its four operating segments.
Speaking at a Morgan Stanley aer
Via MarketBeat · September 17, 2026
GE Aerospace (NYSE:GE) CFO Rahul Ghai said the company continues to see strong demand across commercial services, original equipment and defense programs, despite recent volatility in air traffic growth and persistent aerospace supply-chain constraints.
Speaking at a Morgan Stanley conference, Ghai
Via MarketBeat · September 17, 2026
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7.1% in the afternoon session after the company presented at the Morgan Stanley G...
Via StockStory · September 17, 2026
Ford Motor (NYSE:F) is expanding its software and services strategy around commercial fleets, driver-assistance technology, vehicle maintenance and energy storage, according to Mike Aragon, the company’s President of Integrated Services.
Speaking at a Morgan Stanley conference, Aragon said Ford’s o
Via MarketBeat · September 17, 2026